LLY
ELI LILLY & Co
NYSE · Healthcare · Drug Manufacturers - General · US
$1,152.22
−0.02%Margins
Gross margin
83.4%
EBITDA margin
54.4%
EBIT margin
49.7%
Net margin
33.5%
FCF margin
25.2%
78.8%
Return on equity
18.8%
Return on assets
44.6%
Return on invested capital
0.62x
Asset turnover
$28.1B
Cash from operations
$9.51
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026